Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Actual product packaging and materials may contain more and/or different information than that shown on our Web site
In December 2024, the FDA also approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity
The most commonly prescribed medications in this class include: Ozempic (semaglutide): Originally approved for diabetes, frequently prescribed off-label for weight loss Wegovy (semaglutide): FDA-approved specifically for chronic weight management Mounjaro (tirzepatide): Dual-action diabetes medication increasingly used for weight loss Trulicity (dulaglutide): Weekly injection for diabetes management Rybelsus (oral semaglutide): Oral form of semaglutide for diabetes treatment Serious Health Complications Linked to Weight Loss Drugs The weight loss effectiveness of GLP-1 medications may come at a significant health cost
If blood pressure improves, medication adjustments may be needed
However, any meaningful weight losswhether achieved through medication, dietary changes, bariatric surgery, or intensive lifestyle treatmentcan include some reduction in lean mass
A well-rounded monitoring approach helps you and your healthcare provider make informed decisions while aligning with your personalized dosing plan
